Suchergebnisse - "Goadsby, Peter"

PubPharm (33)

1

Efficacy and Safety of Erenumab in Participants With Episodic Migraine in Whom 2-4 Prior Preventive Treatments Had Failed : LIBERTY 3-Year Study

enthalten in: Neurology | 2024

von Reuter, U. | Goadsby, P. | Ferrari, M. | +9

2

An economic evaluation of eptinezumab for the preventive treatment of migraine in the UK, with consideration for natural history and work productivity

enthalten in: The journal of headache and pain | 2024

von Griffin, E. | Shirley, G. | Lee, X. | +3

3

Calcitonin gene-related peptide-targeting therapies are a first-line option for the prevention of migraine : An American Headache Society position statement update

enthalten in: Headache | 2024

von Charles, A. | Digre, K. | Goadsby, P. | +17

4

Structural equation modeling for identifying the drivers of health-related quality of life improvement experienced by patients with migraine receiving eptinezumab

enthalten in: The journal of headache and pain | 2024

von Jönsson, L. | Awad, S. | Regnier, S. | +4

5

Erenumab in chronic migraine : Experience from a UK tertiary centre and comparison with other real-world evidence

enthalten in: European journal of neurology | 2022

von Khalil, M. | Moreno-Ajona, D. | Villar-Martínez, M. | +3

6

Two-year efficacy and safety of erenumab in participants with episodic migraine and 2-4 prior preventive treatment failures : results from the LIBERTY study

enthalten in: Journal of neurology, neurosurgery, and psychiatry | 2022

von Ferrari, M. | Reuter, U. | Goadsby, P. | +7

7

Assessment of Erenumab Safety and Efficacy in Patients With Migraine With and Without Aura : A Secondary Analysis of Randomized Clinical Trials

enthalten in: JAMA neurology | 2022

von Ashina, M. | Goadsby, P. | Dodick, D. | +5

8

Long-term efficacy and safety of erenumab in migraine prevention : Results from a 5-year, open-label treatment phase of a randomized clinical trial

enthalten in: European journal of neurology | 2021

von Ashina, M. | Goadsby, P. | Reuter, U. | +7

CommentIn: Eur J Neurol. 2021 May;28(5):1439-1440. - PMID 33576558

9

Effect of erenumab on functional outcomes in patients with episodic migraine in whom 2-4 preventives were not useful : results from the LIBERTY study

enthalten in: Journal of neurology, neurosurgery, and psychiatry | 2021

von Lanteri-Minet, M. | Goadsby, P. | Reuter, U. | +4

10

Cost-Effectiveness of Erenumab for the Preventive Treatment of Migraine in Patients with Prior Treatment Failures in Sweden

enthalten in: PharmacoEconomics | 2021

von Mahon, R. | Lang, A. | Vo, P. | +7